The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis

Rheumatology International

Volumn 23, Issue 5, 2003, Pages 231-235

  Tascioglu, Funda ^a   Oner, Cengiz ^a   Armagan, Onur ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Methotrexate; Osteoporosis; Rheumatoid arthritis; Sulphasalazine

Indexed keywords

ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; CALCIFEDIOL; CALCIUM; METHOTREXATE; PARACETAMOL; PARATHYROID HORMONE; PHOSPHORUS; SALAZOSULFAPYRIDINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; PREMENOPAUSE; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0141957590     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0298-z     Document Type: Article

References (42)

1. Van Jaarsveld CH, Jacobs JWG, Van Der Veen MJ, Blaauw AAM, Kruize AA, Hofman DM, Brus HLM (2000) Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 59:468-477
2. Wolfe F (1990) Fifty years of antirheumatic therapy: the prognosis of rheumatoid arthritis. J Rheumatol 17:24-35
3. Prevoo MLL, Van Gestel AM, Van t'Hof MA, Van Rijswýjk MH, Van De Putte LBA, Van Riel PLCM (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101-1105
4. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
5. Dequeker J, Maenaut K, Verwilghen J, Westhowens R (1995) Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 13 [Suppl 12]:S1-S6
6. Suzuki Y, Mizushima Y (1997) Osteoporosis in rheumatoid arthritis. Osteoporos Int 7 [Suppl 3]:S217-S222
7. Celiker R, Gokce-Kutsal Y, Cindas A, Ariyurek M, Renda N, Koray Z, Basgoze O (1995) Osteoporosis in rheumatoid arthritis: effect of disease activity. Clin Rheumatol 14:429-433
8. Laan RFJM, van Riel PLCM, van de Putte LBA (1992) Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 51:826-832
9. Haugeberg G, Uhlig T, Flach JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Results from 394 patients in the Oslo country rheumatoid arthritis register. Arthritis Rheum 43:522-530
10. Kroger H, Honkanen R, Saarikoski S, Alhave E (1994) Decreased axial BMD in perimenopausal women with rheumatoid arthritis - a population-based study. Ann Rheum Dis 53:18-23
11. Iwamoto J, Takeda T, Ichimura S (2002) Forearm bone mineral density in postmenopausal women with rheumatoid arthritis. Calcif Tissue Int 70:1-8
12. Cortet B, Guyot MH, Solau E, Pigny P, Dumoulin F, Flipo RM (2000) Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol 18:683-690
13. Eastgate JA, Wood NC, Di Giovine FS, Symons JA, Grinlinton FM, Duff GW (1988) Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 340:706-709
14. Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309-322
15. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1995) Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 22:1055-1059
16. Saario R, Sonninen P, Mottonen T, Viikari J, Toivanen A (1999) Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis: influence of functional capacity and corticosteroid use. Scand J Rheumatol 28:363-367
17. Weinblatt ME, Majer AL, Fraser PA, Coblyn JJ (1998) Long-term prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. J Rheumatol 25:238-242
18. Ferraccioli GF, Bartoli E (1998) Xenobiotics or biological response modifiers? Methotrexate remains the anchor drug for rheumatoid arthritis. Clin Exp Rheumatol 16:662-666
19. Kerstens PJ, Boerbooms AM, Jeurissen MEC, de Graaf R, Mulder J, van de Putte LB (2000) Radiological and clinical results of long-term treatment of rheumatoid arthritis with methotrexate and azathoprine. J Rheumatol 27:1148-1155
20. Weinblatt ME, Kaplan H, Germain BF, Block S, Solomon SD, Merriman RC (1994) Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 37:1492-1498
21. Schwarts AM, Leonidas JC (1984) Methotrexate osteopathy. Skeletal Radiol 11:13-16
22. Stevens H, Jacobs JWG, Van Rijk P, De Klerk JMH (2001) Methotrexate osteopathy demonstrated by Technetium-99m HDP scintigraphy. Clin Nuc Med 5:389-391
23. Maenpaa HM, Soini I, Lehto MUK, Belt EA (2002) Insufficiency fractures in patients with chronic inflammatory joint disease. Clin Exp Rheumatol 20:77-79
24. Zonneveld IM, Bakker WK, Dijkstra PF, Bos JD, van Soesbergen RM, Dinant HJ (1996) Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol 132:184-187
25. May KP, Mercill D, Mcdermott MT, West SG (1996) The effect of methorexate on mouse bone cells in culture. Arthritis Rheum 39:489-494
26. Van Der Veen MC, Scheven BAA, Van Roy JLAM, Damen CA, Lafeber FPJG, Bulsma JWJ (1996) In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts. Br J Rheumatol 35:342-349
27. Blum M, Wallenstein CJ, Luckey M (1996) Effect of methotrexate on bone in postmenopausal women with primary biliary cirrhosis. J Bone Miner Res 11:T545
28. Cranney AB, McKendry RJ, Wells GA, Daylily SOOI, Kanisberg ND, Kraag GR, Smith D (2001) The effect of low dose methotrexate on bone density. J Rheumatol 28:2395-2399
29. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1997) Effects of low dose methotrexate on bone mineral density of patients with rheumatoid arthritis. J Rheumatol 29 1489-1494
30. Mazzantini M, Di Munno O, Incerti-Vecchi L, Pasero G (2000) Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 18:327-331
31. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
32. Prevoo MLL, Van t'Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
33. Kirwan JR, Reeback JS (1986) Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206-209
34. Buchbinder R, Hall S, Sambrook PN, Champion GD, Harkness A, Lewis D, Littlejohn GO, Miller MH, Ryan PF (1993) Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 20:639-644
35. Wluka A, Buchbinder R, Mylvaganam A, Hall S, Harkness A, Lewis D, Littlejohn GO, Miller MH, Ryan PF (2000) Long-term methotrexate use in rheumatoid arthritis: 12 year follow-up of 460 patients treated in community practice. J Rheum 27:1864-1871
36. Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on bone mass in rheumatoid arthritis. J Rheumatol 27:2582-2589
37. Preston SJ, Clifton-Bligh P, Laurent MR, Jackson C, Mason RS (1997) Effect of methotrexate and sulphasalazine on UMR 106 rat osteosarcoma cells. Br J Rheumatol 36:178-184
38. Cantatore FP, Acquista CA, Pipitone V (1999) Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 26:2318-2323
39. 2-microglobulin in postmenopausal osteoporosis. Calcif Tissue Int 53:78-80
40. Moe SM, Sprague SM (1992) Beta2-microglobulin induces calcium efflux from cultured neonatal mouse calvaria. Am J Physiol 263:540-545
41. Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring EF, Bhalla AK (1994) Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33:541-545
42. Keller C, Hafström I, Svensson B (2001) Bone mineral density in women and men with early rheumatoid arthritis. Scand J Rheumatol 30:213-220